An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate

Toxicological Sciences

Volumn 55, Issue 1, 2000, Pages 133-142

  Bowyer, John F ^a,b   Newport, Glenn D ^a   Slikker Jr , William ^a   Gough, Bobby ^a   Ferguson, Sherry A ^a   Tor Agbidye, John ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b NCTR   (United States)

Author keywords

Dopamine; Ephedrine; Microdialysis; Neurotoxicity; Serotonin; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DEXAMPHETAMINE; DOPAMINE; EPHEDRINE; GLUTAMIC ACID; HOMOVANILLIC ACID; NOREPHEDRINE; SEROTONIN;

ANIMAL MODEL; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTHERMIA; MALE; MICRODIALYSIS; NEUROTOXICITY; NONHUMAN; PUTAMEN; RAT;

EID: 0034067258     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/55.1.133     Document Type: Article

References (52)

1. Bell, D. G., Jacobs I., McLellan, T. M., Miyazaki, M. and Sabiston, C. M. (1999). Thermal regulation in the heat during exercise after caffeine and ephedrine ingestion. Aviat. Space Environ. Med. 70, 583-588.
2. Bell, D. G., Jacobs, I., and Zamecnik, J. (1998). Effects of caffeine, ephedrine, and their combination on time to exhaustion during high-intensity exercise. Eur. J. Appl. Physiol. 77, 427-433.
3. Bowyer, J. F., Clausing, P., Gough, B., Slikker, W., Jr., and Holson, R. R. (1995a). Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res. 699, 62-70.
4. Bowyer, J. F., Clausing, P., and Newport, G. D. (1995b). Determination of d-amphetamine in biological samples using high performance liquid chromatography after pre-column derivatization with o-phthaldialdehyde and 3-mercaptopropionic acid. J. Chromatogr. B. Biomed. Appl. 666, 241-250.
5. Bowyer, J. F., Davies, D. L., Schmued, L., Broening, H. W., Newport, G. D., Slikker, W., Jr., and Holson, R. R. (1994). Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268, 1571-1580.
6. Bowyer, J. F., Gough, B., Slikker, W., Jr., Lipe, G. W., Newport, G. D., and Holson, R. R. (1993). Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol. Biochem. Behav. 44, 87-98.
7. Bowyer, J. F., and Holson, R. R. (1995). Methamphetamine and amphetamine neurotoxicity. In Handbook of Neurotoxicology (L. W. Chang and R. S. Dyer, Eds.), pp. 845-870. Marcel Dekker, New York.
8. Bowyer, J. F., Peterson, S. L., Rountree, R. L., Tor-Agbidye, J., and Wang, G. J. (1998). Neuronal degeneration in rat forebrain resulting from D-amphetamine-induced convulsions is dependent on seizure severity and age. Brain Res. 809, 77-90.
9. Bowyer, J. F., Tank, A. W., Newport, G. D., Slikker, W., Jr., Ali, S. F. and Holson, R. R. (1992). The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260, 817-824.
10. Bruno, A., Nolte, K. B., and Chapin, J. (1993). Stroke associated with ephedrine use. Neurology. 43, 1313-1316.
11. Chase, S. L. (1996). The FDA warns of the dangers of ephedrine. RN 59, 67.
12. Chen, K. K., and Schmidt, C. F. (1930). Ephedrine and related substances. Medicine, Baltimore 9, 1-117.
13. Clausing, P., Gough, B., Holson, R. R., Slikker, W., Jr., and Bowyer, J. F. (1995). Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra, and plasma after dosage that produces either behavioral or neurotoxic effects. J. Pharmacol. Exp. Ther. 274, 614-621.
14. Clausing, P., Rushing, L. G., Newport, G. D., and Bowyer, J. F. (1997). Determination of D-fenfluramine, D-norfenfluramine, and fluoxetine in plasma, brain tissue, and brain microdialysate using high-performance liquid chromatography after pre-column derivatization with dansyl-chloride. J. Chromatogr. B. Biomed. Sci. App. 692, 419-426.
15. Commins, D. L., and Seiden, L. S. (1986). Alpha-methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex. Brain Res. 365, 15-20.
16. Eisch, A. J., and Marshall, J. F. (1998). Methamphetamine neurotoxicity: Dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse 30, 433-445.
17. Ferguson, S. A., Paule, M. G., and Holson, R. R. (1996). Functional effects of methylazoxymethanol-induced cerebellar hypoplasia in rats. Neurotoxicol. Teratol. 18, 529-537.
18. Gibb, J. W., and Kogan, F. J. (1979). Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch. Pharmacol. 310, 185-187.
19. Godel, H., Graser, T., Foldi, P., Pfaender, P., and Furst, P. (1984). Measurement of free amino acids in human biological fluids by high-performance liquid chromotography. J. Chromatog. 297, 49-61.
20. Graham, D. G. (1978). Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643.
21. Hotchkiss, A. J., and Gibb, J. W. (1980). Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214, 257-262.
22. Jacobs, B. L. (1976). An animal behavior model for studying central serotonergic synapses. Life Sci. 19, 777-785.
23. James, L. P., Farrar, H. C., Komoroski, E. M., Wood, W. R., Graham, C. J., Bornemeier, R. A., and Valentine, J. L. (1998). Sympathomimetic drug use in adolescents presenting to a pediatric emergency department with chest pain. J. Toxicol. Clin. Toxicol. 36, 321-328.
24. Josefson, D. (1996). Herbal stimulant causes U.S. deaths. Brit. Med. J. 312, 1378-1379.
25. Kalant, H., and Kalant, O. J. (1975). Death in amphetamine users: Causes and rates. Can. Med. Assoc. J. 112, 299-304.
26. Keplinger, M. L., Lanier, G. E., and Deichmann, W. B. (1959). Effects of environmental temperature on the acute toxicity of a number of compounds in rats. Toxicol. Appl. Pharmacol. 1, 156-161.
27. La Voie, M. J., and Hastings, T. G. (1999). Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine. J. Neurosci. 19, 1484-1491.
28. 11C]WIN-35,428. J. Neurosci. 18, 8417-8422.
29. Melega, W. P., Williams, A. E., Schmitz, D. A., DiStefano, E. W., and Cho, A. K. (1995). Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal. J. Pharmacol Exp. Ther. 274, 90-96.
30. Miller, D. B. and O'Callaghan, J. P. (1994). Environment-, drug-, and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270, 752-760.
31. Nahorski, S. R. (1980). Acute and chronic effects of amphetamine on cerebral energy metabolism and cyclic nucleotides. In Amphetamines and Related Stimulants: Chemical, Biological, Clinical, and Social Aspects (J. Caldwell, Ed.), pp. 85-96. CRC Press, Boca Raton, FL.
32. Nash, J. F., and Yamamoto, B. K. (1992). Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581, 237-243.
33. O'Dell, S. J., Weihmuller, F. B., and Marshall, J. F. (1991). Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine, which correlate with subsequent neurotoxicity. Brain Res. 564, 256-260.
34. Paxinos, G., and Watson, C (1995). The Rat Brain in Stereotaxic Coordinates, Vol.2. Academic Press, San Diego.
35. Ricaurte, G. A., Fuller, R. W., Perry, K. W., Seiden, L. S., and Schuster, C. R. (1983). Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine. Neuropharmacol. 10, 1165-1169.
36. Schmidt, C. J., Black, C. K., Taylor, V. L., Fadayel, G. M., Humphreys, T. M., Nieduzak, T. R., and Sorenson, S. M. (1992). The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine. Eur. J. Pharm. 220, 151-159.
37. Schmidt, C. J., Ritter, J. K., Sonsalla, P. K., Hanson, G. R., Gibb, J. W. (1985). Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233, 539-544.
38. Schmued, L. C., and Bowyer, J. F. (1997). Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res. 759, 135-140.
39. Seiden, L. S., and Sabol, K. E. (1995). Neurotoxicity of methamphetamine-related drugs and cocaine. In Handbook of Neurotoxicology (L. W. Chang and R. S. Dyer, Eds.), Vol. 2, pp. 824-844. Marcel Dekker, New York.
40. Sellers, E. M., Martin, P. R., Roy, M. L., and Sellers, E. A. (1979). Amphetamines. In Body Temperature: Regulation, Drug Effects, and Therapeutic Implications (P. Lomax and E. Schonbaum, Eds.), pp. 461-499. Marcel Dekker. New York.
41. Sonsalla, P. K., Nicklas, W. J. and Heikkila, R. E. (1989). Role for excitatory amino acids in methamphetamine-inducd nigrostriatal dopaminergic toxicity. Science 243, 398-400.
42. Stephans, S. E., Whittingham, T. S., Douglas, A. J., Lust, W. D., and Yamamoto, B. K. (1998). Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum. J. Neurochem. 71, 613-621.
43. Stephans, S. E., and Yamamoto, B. K. (1994). Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux. Synapse 17, 203-209.
44. Stokes, A. H., Hastings, T. G., and Vrana, K. E. (1999). Cytotoxic and genotoxic potential of dopamine. J. Neurosic. Res. 55, 659-665.
45. Tinsley, J. A., and Watkins, D. D. (1998). Over-the-counter stimulants: Abuse and addiction. Mayo Clin. Proc. 73, 977-982.
46. Vanakoski, J., Stromberg, C., and Seppala, T. (1993). Effects of a sauna on the pharmacokinetics and pharmacodynamics of midazolam and ephedrine in healthy young women. Euro. J. Clin. Pharmacol. 45, 337-381.
47. Weihmuller, F. B., O'Dell, S. J., and Marshall, J. F. (1992). MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 11, 155-163.
48. White, L. M., Gardner, S. F., Gurley, B. J., Marx, M. A., Wang, P. L., and Estes, M. (1997). Pharmacokinetics and cardiovascular effects of ma-haung (Ephedra sinica) in normotensive adults. J. Clin. Pharmacol, 37, 116-122.
49. Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W. and Kish, S. J. (1996). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 2, 699-703.
50. Yamamoto, B. K., and Zhu, W. (1998). The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 287, 107-114.
51. Zalis E. G., and Parmley, L. F., Jr. (1963). Fatal amphetamine poisoning. Arch. Int. Med. 112, 822-826.
52. Zalis, E. G., Lundberg, G. D., and Knutson, R. A. (1967). The pathophysiology of acute amphetamine poisoning with pathologic correlation. J. Pharmacol. Exp. Ther. 158, 115-127.